- Home
- PRE vs RCKT Comparison
PRE vs RCKT Comparison
Compare PRE & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRE | RCKT |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | Hong Kong | United States |
| Employees | 98 | 202 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 337.6M | 401.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRE | RCKT |
|---|---|---|
| Price | $21.26 | $2.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $30.50 | $29.73 |
| AVG Volume (30 Days) | 299.1K | ★ 2.4M |
| Earning Date | 06-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $108.69 | N/A |
| Revenue Next Year | $58.68 | $64.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.01 | $2.40 |
| 52 Week High | $23.63 | $5.45 |
Technical Indicators
Market Signals| Indicator | PRE | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 41.21 |
| Support Level | $12.92 | N/A |
| Resistance Level | $21.72 | $3.42 |
| Average True Range (ATR) | 1.86 | 0.15 |
| MACD | 0.17 | 0.01 |
| Stochastic Oscillator | 77.81 | 49.19 |
Price Performance
Historical ComparisonAbout PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.